Pay in 4 interest-free payments of $5.44 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Microbiology 111(2):313326
Nasrallah & Alzeer, 2022) and post-mortem studies(Chauhan et al., 2012
Innovations like nanoencapsulation could transition nutraceuticals from supplements to precision medicine adjuvants, pending resolution of doseresponse ambiguities and long-term safety gaps through targeted research
13.3.5 Virulence trait expression and reversion risk Of particular concern in the safety evaluation of probiotics is their potential for virulence reversion, a risk that is markedly higher in strains of pathogenic origin, particularly under favorable environmental conditions
JAMA 331 , 740749 (2024)
US$ 21.30
US$ 28.31
US$ 25.35
